BiomaterialsAcute Kidney InjuryAnimalsOxidative StressMolybdenumEnergy Metabolism
Mo2C nanozyme targets citrate synthase to treat acute kidney injury through alleviating oxidative stress and dysfunction of energy metabolism.
Wei Wei, Yuyi Zhu, Xiaoqin Shui, Caihong Liu, Yongxiu Huang, Jinglei Ren, Chang Liu, Letian Yang, Liang Ma, Meng Gong, Ping Fu, Dingkun Zhang, Yuliang Zhao
Published: 202610.1016/j.biomaterials.2025.123845
Abstract
Acute kidney injury (AKI), characterized by rapid renal dysfunction, lacks effective therapies due to its complex pathophysiology involving oxidative stress and mitochondrial damage. Molybdenum carbide (Mo2C) nanozymes show promise through their tuna…
Preview only. Read the full abstract at the source